Autopsy report · NCT01522300

Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity Search

“No more inclusions since august 2013”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 7 months before it stopped.
• 81 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

Centre Jean Perrin

Sponsor type

University, hospital or other

Conditions

Mammary Tumor

Interventions

Evaluation of the Tomosynthesis; Avaluation of a medical device: the tomosynthesis

Participants

81

Sites

1

Countries

France

Trials that died the same way

• EXOme Rare Cancers in Children (EXOCARE)
  “Inclusions stopped due to lack of inclusions” (75% match in meaning)
• Pronostic Value of Endothelial Dysfunction in Heart Failure
  “Not enough inclusions” (71% match in meaning)
• Transfusion Effects in Myelodysplastic Patients: Limiting Exposure
  “Too few inclusions” (70% match in meaning)
• Development of a Predictive Score for Local Complications of Femoral Bifurcation Surgery
  “lack of inclusions” (69% match in meaning)
• Intra-Osseous Access in Difficult Vascular Access Cases
  “Lack of inclusion” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.